What, if all alerts were specific - Estimating the potential impact on drug interaction alert burden

PURPOSE Clinical decision support systems (CDSS) may potentially improve prescribing quality, but are subject to poor user acceptance. Reasons for alert overriding have been identified and counterstrategies have been suggested; however, poor alert specificity, a prominent reason of alert overriding, has not been well addressed. This paper aims at structuring modulators that determine alert specificity and estimating their quantitative impact on alert burden. METHODS We developed and summarized optimizing strategies to guarantee the specificity of alerts and applied them to a set of 100 critical and frequent drug interaction (DDI) alerts. Hence, DDI alerts were classified as dynamic, i.e. potentially sensitive to prescription-, co-medication-, or patient-related factors that would change alert severity or render the alert inappropriate compared to static, i.e. always applicable alerts not modulated by cofactors. RESULTS Within the subset of 100 critical DDI alerts, only 10 alerts were considered as static and for 7 alerts, relevant factors are not generally available in today's patient charts or their consideration would not impact alert severity. The vast majority, i.e. 83 alerts, might require a decrease in alert severity due to factors related to the prescription (N=13), the co-medication (N=11), individual patient data (N=36), or combinations of them (N=23). Patient-related factors consisted mainly of three lab values, i.e. renal function, potassium, and therapeutic drug monitoring results. CONCLUSION This paper outlines how promising the refinement of knowledge bases is in order to increase specificity and decrease alert burden and suggests how to structure knowledge bases to refine DDI alerting.

[1]  P. Beeler,et al.  Clinical decision support for monitoring drug-drug-interactions and potassium-increasing drug combinations: need for specific alerts. , 2012, Studies in health technology and informatics.

[2]  W. Paul Nichol,et al.  Research Paper: Practitioners' Views on Computerized Drug-Drug Interaction Alerts in the VA System , 2007, J. Am. Medical Informatics Assoc..

[3]  A. Avery,et al.  GPs' views on computerized drug interaction alerts: questionnaire survey , 2002, Journal of clinical pharmacy and therapeutics.

[4]  Christopher D. Wickens,et al.  The benefits of imperfect diagnostic automation: a synthesis of the literature , 2007 .

[5]  P. Glassman,et al.  Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. , 2003, Journal of managed care pharmacy : JMCP.

[6]  K. Baisley,et al.  Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. , 2012, British journal of clinical pharmacology.

[7]  A. Vitry,et al.  Comparative assessment of four drug interaction compendia. , 2007, British journal of clinical pharmacology.

[8]  Roger B. Davis,et al.  Clinicians' assessments of electronic medication safety alerts in ambulatory care. , 2009, Archives of internal medicine.

[9]  David W. Bates,et al.  Coded entry versus free-text and alert overrides: What you get depends on how you ask , 2010, Int. J. Medical Informatics.

[10]  J. Feinglass,et al.  The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. , 2004, Archives of internal medicine.

[11]  S. Asch,et al.  Clinical Relevance of Automated Drug Alerts From the Perspective of Medical Providers , 2005, American journal of medical quality : the official journal of the American College of Medical Quality.

[12]  David W. Bates,et al.  Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems - I-MeDeSA , 2011, J. Am. Medical Informatics Assoc..

[13]  R Khajouei,et al.  The Impact of CPOE Medication Systems’ Design Aspects on Usability, Workflow and Medication Orders , 2010, Methods of Information in Medicine.

[14]  Roger B. Davis,et al.  Physicians' decisions to override computerized drug alerts in primary care. , 2003, Archives of internal medicine.

[15]  S. Goergen,et al.  Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. , 2010, Radiology.

[16]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[17]  A. Localio,et al.  Role of computerized physician order entry systems in facilitating medication errors. , 2005 .

[18]  Martin Jung,et al.  RESEARCH ARTICLE Open Access Development of a context model to prioritize drug safety alerts in CPOE systems , 2022 .

[19]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[20]  P. Glassman,et al.  Improving Recognition of Drug Interactions: Benefits and Barriers to Using Automated Drug Alerts , 2002, Medical care.

[21]  Jens Kaltschmidt,et al.  Successful strategy to improve the specificity of electronic statin–drug interaction alerts , 2009, European Journal of Clinical Pharmacology.

[22]  A. Egberts,et al.  Clinical Risk Management in Dutch Community Pharmacies , 2006, Drug safety.

[23]  J. McCulloch,et al.  CHAPTER 7 – Implications for Prevention , 1972 .

[24]  Gerd Mikus,et al.  Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir , 2006, Clinical pharmacology and therapeutics.

[25]  Marc Berg,et al.  Case Report: Time-dependent Drug-Drug Interaction Alerts in Care Provider Order Entry: Software May Inhibit Medication Error Reductions , 2009, J. Am. Medical Informatics Assoc..

[26]  Yoshiaki Yamamoto,et al.  Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients. , 2012, Biological & pharmaceutical bulletin.

[27]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[28]  Marc Berg,et al.  Overriding of drug safety alerts in computerized physician order entry. , 2006, Journal of the American Medical Informatics Association : JAMIA.

[29]  C. Timmer,et al.  Mirtazapine in combination with amitriptyline: a drug–drug interaction study in healthy subjects , 2003, Human psychopharmacology.

[30]  Donna C. Dare,et al.  Reasons provided by prescribers when overriding drug-drug interaction alerts. , 2007, The American journal of managed care.

[31]  P. Hansten,et al.  Customizing clinical decision support to prevent excessive drug-drug interaction alerts. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  Diane L. Seger,et al.  Viewpoint Paper: Tiering Drug-Drug Interaction Alerts by Severity Increases Compliance Rates , 2009, J. Am. Medical Informatics Assoc..

[33]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .

[34]  Yu Ko,et al.  Clinically Significant Drug–Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia , 2008, The Annals of pharmacotherapy.

[35]  David W Bates,et al.  Mixed results in the safety performance of computerized physician order entry. , 2010, Health affairs.

[36]  Diane L. Seger,et al.  Application of Information Technology: Improving Acceptance of Computerized Prescribing Alerts in Ambulatory Care , 2006, J. Am. Medical Informatics Assoc..

[37]  Almut G Winterstein,et al.  Nature and causes of clinically significant medication errors in a tertiary care hospital. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.